Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility

被引：2

作者：

Beligotti, Fabiola ^{[1
]}

机构：

[1] Ferring Pharmaceut, Reprod Med & Maternal Hlth, St Prex, Switzerland

来源：

FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷

关键词：

human menopausal gonadotrophin (hMG); assisted reproductive technologies (ART); ovarian stimulation; follicle stimulating hormone (FSH); follitropin delta;

D O I：

10.3389/fendo.2020.00151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 5 条

[1] Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial [J].

Andersen, Anders Nyboe ;

Nelson, Scott M. ;

Fauser, Bart C. J. M. ;

Garcia-Velasco, Juan Antonio ;

Klein, Bjarke M. ;

Arce, Joan-Carles .

FERTILITY AND STERILITY, 2017, 107 (02) :387-+

[2]

European Medicines Agency, 2017, REK FOLL DELT

[3] Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders (vol 32, pg 544, 2017) [J].

Humaidan, P. ;

Chin, W. ;

Rogoff, D. ;

D'Hooghe, T. ;

Longobardi, S. ;

Hubbard, J. ;

Schertz, J. .

HUMAN REPRODUCTION, 2017, 32 (07) :1537-1538

[4] Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders [J].

Humaidan, P. ;

Chin, W. ;

Rogoff, D. ;

D'Hooghe, T. ;

Longobardi, S. ;

Hubbard, J. ;

Schertz, J. .

HUMAN REPRODUCTION, 2017, 32 (03) :544-555

[5]

Therapeutic Goods Administration (TGA) Commonwealth of Australia, 2017, AUSTR PUBL ASS REP A

← 1 →